These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 8074564)

  • 1. [Ciprofloxacin in the treatment of staphylococcal endocarditis].
    Demin AA; Drobysheva VP
    Antibiot Khimioter; 1993; 38(2-3):40-2. PubMed ID: 8074564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacies of moxifloxacin, ciprofloxacin, and vancomycin against experimental endocarditis due to methicillin-resistant Staphylococcus aureus expressing various degrees of ciprofloxacin resistance.
    Entenza JM; Que YA; Vouillamoz J; Glauser MP; Moreillon P
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3076-83. PubMed ID: 11600359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ciprofloxacin resistance and staphylococcal endocarditis.
    Lancet; 1989 Dec 23-30; 2(8678-8679):1525-6. PubMed ID: 2574800
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of right-sided Staphylococcus aureus endocarditis in intravenous drug users with ciprofloxacin and rifampicin.
    Dworkin RJ; Lee BL; Sande MA; Chambers HF
    Lancet; 1989 Nov; 2(8671):1071-3. PubMed ID: 2572799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of ciprofloxacin in treatment and prophylaxis of experimental Staphylococcus aureus endocarditis caused by a cloxacillin-tolerant strain and its non-tolerant variant.
    Voorn GP; Thompson J; Goessens WH; Schmal-Bauer WC; Broeders PH; Michel MF
    J Antimicrob Chemother; 1994 Apr; 33(4):785-94. PubMed ID: 8056697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Right endocarditis caused by Staphylococcus aureus in parenteral drug addicts: evaluation of a combined therapeutic scheme for 2 weeks versus conventional treatment].
    Espinosa FJ; Valdés M; Martín-Luengo F; Arribas JP; Albaladejo J; Pérez-Gracia A; García-Henarejos JA; Martínez-Madrid O; García-Alberola A
    Enferm Infecc Microbiol Clin; 1993 May; 11(5):235-40. PubMed ID: 8324018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early resistance to rifampin and ciprofloxacin in the treatment of right-sided Staphylococcus aureus endocarditis.
    Tebas P; Martinez Ruiz R; Roman F; Mendaza P; Rodriguez Diaz JC; Daza R; de Letona JM
    J Infect Dis; 1991 Jan; 163(1):204-5. PubMed ID: 1984473
    [No Abstract]   [Full Text] [Related]  

  • 8. High-dose daptomycin for cardiac implantable electronic device-related infective endocarditis.
    Durante-Mangoni E; Casillo R; Bernardo M; Caianiello C; Mattucci I; Pinto D; Agrusta F; Caprioli R; Albisinni R; Ragone E; Utili R
    Clin Infect Dis; 2012 Feb; 54(3):347-54. PubMed ID: 22100575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of difloxacin, enoxacin, and cefazolin for the treatment of experimental Staphylococcus aureus endocarditis.
    Boscia JA; Kobasa WD; Kaye D
    Antimicrob Agents Chemother; 1988 Feb; 32(2):262-4. PubMed ID: 3163241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of ciprofloxacin in animal models of infection: endocarditis, meningitis, and pneumonia.
    Sande MA; Brooks-Fournier RA; Gerberding JL
    Am J Med; 1987 Apr; 82(4A):63-6. PubMed ID: 3578331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous followed by oral antimicrobial therapy for staphylococcal endocarditis.
    Chayakul P; Yipintsoi T
    J Med Assoc Thai; 1993 Oct; 76(10):559-63. PubMed ID: 7964226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ceftriaxone in the treatment of staphylococcal endocarditis].
    Demin AA; Drobysheva VP
    Antibiot Khimioter; 1998; 43(6):12-5. PubMed ID: 9644528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of less severe aortic valve destruction after treatment of experimental staphylococcal endocarditis with vancomycin and dexamethasone.
    Siaperas P; Pefanis A; Iliopoulos D; Katsarolis I; Kyroudi-Voulgari A; Donta I; Karayiannakos P; Giamarellou H
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3531-7. PubMed ID: 11709335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Staphylococcus aureus endocarditis using moxifloxacin.
    Berrington AW; Koerner RJ; Perry JD; Bain HH; Gould FK
    Int J Med Microbiol; 2001 Aug; 291(3):237-9. PubMed ID: 11554565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nafcillin-gentamicin synergism in experimental staphylococcal endocarditis.
    Sande MA; Courtney KB
    J Lab Clin Med; 1976 Jul; 88(1):118-24. PubMed ID: 1047088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Infective endocarditis of staphylococcal etiology: clinical process and antibacterial therapy].
    Iakovlev SV; Shcheka DV; Suvorova MP; Sergeeva EV; Cherkasova NA
    Antibiot Khimioter; 2009; 54(5-6):59-64. PubMed ID: 20052920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-course combination and oral therapies of Staphylococcus aureus endocarditis.
    Chambers HF
    Infect Dis Clin North Am; 1993 Mar; 7(1):69-80. PubMed ID: 8463654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic effect of ME1036 on endocarditis experimentally induced by methicillin-resistant Staphylococcus aureus.
    Nagura J; Kijima K; Kurazono M; Takahata S; Sugano T; Tanaka Y; Hirai Y; Yamada K; Takayama Y; Shitara E; Yonezawa M
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3526-8. PubMed ID: 16048975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of MRSA infections].
    Borde JP; Kern WV
    Dtsch Med Wochenschr; 2012 Dec; 137(49):2553-7. PubMed ID: 23143638
    [No Abstract]   [Full Text] [Related]  

  • 20. In vivo acquired daptomycin resistance during treatment of methicillin-resistant Staphylococcus aureus endocarditis.
    Dortet L; Anguel N; Fortineau N; Richard C; Nordmann P
    Int J Infect Dis; 2013 Nov; 17(11):e1076-7. PubMed ID: 23578850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.